Matthew T Seymour

10PUBLICATIONS
111CO-AUTHORS
Community ecology (excl. invasive species ecology)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2023
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer.

Christopher J M Williams, Faye Elliott, Nancy Sapanara

|Jan 19, 2023
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial.

Dion Morton, Matthew Seymour, Laura Magill

|May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials.

Nadine J McCleary, William S Harmsen, Ellana Haakenstad

|Sep 20, 2021
Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring.

Jenny F Seligmann, David J Fisher, Louise C Brown

|Sep 13, 2021
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial.

Richard A Adams, David J Fisher, Janet Graham

Pageof 2